المساعد الشخصي الرقمي

مشاهدة النسخة كاملة : REFILE-BRIEF-U.S. FDA Grants Breakthrough Therapy Designation for Genentech?s Investi


ahlam1399
09-04-2015, 10:27 AM
REFILE-BRIEF-U.S. FDA Grants Breakthrough Therapy Designation for Genentech?s Investigational Medicine ACE910 for People With Hemophilia A With Factor VIII Inhibitors
Sept 4 (Reuters) - Sept 4 (Reuters) - Genentech: * U.S. FDA grants breakthrough therapy designation forGenentech's investigational medicine ACE910 for people withHemophilia A with factor VIII...http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=EoJ8cmZ2lRk:AbB5O2vpXsQ:yI l2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=EoJ8cmZ2lRk:AbB5O2vpXsQ:V_ sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=EoJ8cmZ2lRk:AbB5O2vpXsQ:V_ sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=EoJ8cmZ2lRk:AbB5O2vpXsQ:F7 zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=EoJ8cmZ2lRk:AbB5O2vpXsQ:F7 zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/governmentfilingsNews/~4/EoJ8cmZ2lRk